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Commercially produced spray-dried porcine plasma contains increased 
concentrations of porcine circovirus type 2 DNA but does not 
transmit porcine circovirus type 2 when fed to naïve pigs
H. G. Shen,* S. Schalk,* P. G. Halbur,* J. M. Campbell,† L. E. Russell,†‡  
and T. Opriessnig*1
*Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine,  
Iowa State University, Ames, 50011; †APC Inc., Ankeny, IA 50021;  
and ‡North American Spray-Dried Blood and Plasma Producers, Arlington, VA 22201
ABSTRACT: The porcine circovirus type 2 (PCV2) 
antibody and DNA status of porcine plasma products 
collected during the commercial spray-drying process 
were evaluated. Samples evaluated included 52 pooled 
liquid plasma (fresh) samples collected at 14 regional 
abattoirs before transport to 1 of 2 spray-drying fa-
cilities, 32 pooled liquid plasma (concentrated) samples 
collected after arrival at the spray-drying facilities at 
different stages before the spray-drying process, and 32 
samples in powdered form (spray-dried) collected after 
spray drying. All 116 samples were positive for PCV2 
antibody, with PCV2 ELISA sample-to-positive ratios 
ranging from 9.2 to 13.6 on a DM basis. Porcine circo-
virus type 2 DNA (4.5 to 7.9 log10 PCV2 copies/mL, 
DM basis) was present in 82.7% (43/52) of the fresh 
plasma samples, 71.9% (23/32) of the concentrated 
plasma samples and 78.1% (25/32) of the spray-dried 
plasma samples, with a greater prevalence of PCV2b 
than PCV2a. To determine the infectivity of PCV2 
DNA-positive commercial spray-dried plasma, nine 
10-wk-old 68-kg PCV2-naïve pigs were randomly as-
signed to 1 of 3 treatment groups and rooms: 1) a nega-
tive control (no plasma in the feed, not inoculated with 
PCV2); 2) a positive control (no plasma in the feed, 
inoculated with PCV2); and 3) plasma-fed pigs (4% 
porcine plasma in the feed for 42 d, not inoculated with 
PCV2). All positive control pigs became viremic by 7 d 
postinoculation and seroconverted by 42 d postinocula-
tion, whereas pigs in the negative control group and in 
the spray-dried plasma group were PCV2 PCR nega-
tive and did not seroconvert to PCV2 for the duration 
of the study. The results indicate that PCV2 DNA and 
antibodies are commonly found in commercial spray-
dried plasma. However, no evidence of infectivity of the 
PCV2 DNA was found in naïve pigs when commercial 
spray-dried plasma was included in the diet under the 
conditions of this study.
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INTRODUCTION
Porcine circovirus (PCV) type 2 (PCV2), a small, 
circular, nonenveloped, single-stranded DNA virus 
(Tischer et al., 1982), is the etiological agent of PCV-
associated disease (PCVAD; Opriessnig et al., 2007). 
Serological surveys have shown that most herds world-
wide are infected with PCV2 (Allan and Ellis, 2000; 
Walker et al., 2000; Zhou et al., 2006). Subclinical 
PCV2 infections are common in pig populations, and 
only a small percentage of pigs develop clinical PCVAD 
(Calsamiglia et al., 2002; Segalés and Domingo, 2002). 
Porcine circovirus type 2 can be transmitted horizon-
tally by shedding via the oronasal, fecal, and urinary 
routes (Magar et al., 2000; Bolin et al., 2001; Shibata 
et al., 2003; Yang et al., 2003) or can be transmitted 
vertically (Larochelle et al., 2000; Kim et al., 2001; Mc-
Intosh et al., 2006; Madson et al., 2008).
Spray-dried porcine plasma is commonly included 
in diets for weanling pigs (Coffey and Cromwell, 2001; 
Van Dijk et al., 2001; USDA, 2008). Porcine circovirus 
type 2 is resistant to dry-heat treatment (120°C for 
30 min; Welch et al., 2006) and wet-heat treatment 
(70°C for 15 min; Allan et al., 1994; O’Dea et al., 2008). 
Therefore, when considering the widespread nature of 
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the infection, it is important to determine if spray-dried 
porcine plasma represents a significant vector for the 
spread of PCV2 infection. Recently, Patterson et al. 
(2010) reported that experimentally produced spray-
dried porcine plasma, collected using a benchtop labo-
ratory spray drier from a single pig infected with PCV2 
exhibiting clinically manifest PCVAD, was capable of 
transmitting PCV2 to naïve pigs via intraperitoneal in-
oculation or oral gavage.
The purpose of the current study was to provide in-
formation on the prevalence of PCV2 DNA and anti-
PCV2 antibodies in commercially produced porcine 
plasma at different stages of production and to further 
investigate the potential transmission of PCV2 when 
commercially produced porcine plasma was included in 
the diets of naïve pigs.
MATERIALS AND METHODS
The experimental protocol in this study was approved 
by the Iowa State University Institutional Animal Care 
and Use Committee.
Spray-Dried Plasma Survey
Overview of the Spray-Drying Production 
Process. During slaughter at 14 federally inspected 
abattoirs located in the United States, plasma is col-
lected from each pig and pooled at each individual fa-
cility. On a daily basis, the plasma is collected from 
the abattoirs and transported in insulated tankers to 
2 spray-drying facilities located in the Southeast and 
Midwest areas of the United States. One facility re-
ceives plasma from 6 of the abattoirs located in the 
eastern one-half of the United States, whereas the other 
facility receives plasma from 9 of the abattoirs located 
in the Midwest (1 abattoir supplies plasma to both fa-
cilities). A tanker contains plasma from approximately 
9,000 to 10,000 pigs.
Sample Collection, Storage, and Transport. 
Pooled liquid plasma (8% solids; n = 52) from each of 
the 14 federally inspected plants was collected from the 
tankers on arrival at the spray-drying facility in 50-
mL conical tubes on 4 different days at different time 
points.
At the spray-drying facility, plasma from 1 to 3 tank-
ers was combined in a holding silo and scheduled for 
concentration and spray drying according to the nor-
mal production protocol. Samples of both concentrated 
liquid (28 to 30% solids; n = 32) and dried (91 to 93% 
solids; n = 32) plasma were collected at 4 different time 
points throughout the production cycle. To adequately 
characterize each production run, samples were taken 
after initial stabilization of the spray-drying process at 
the start of each run (beginning), after approximately 
one-third of the production run (middle 1), after ap-
proximately two-thirds of the production run (middle 
2), and just before the spray dryer shut down (end of 
the production run).
All plasma samples were immediately frozen after 
collection and stored at −20°C. Samples were shipped 
frozen overnight on wet ice to the analytical laboratory, 
where they were immediately stored at −80°C until 
testing.
PCV2 Serology. The presence and quantity of 
anti-PCV2 antibodies were determined using an open-
reading frame 2-based PCV2 IgG ELISA (Nawagitgul 
et al., 2002). Before detection, spray-dried samples 
were diluted at 0.167 g/mL in normal saline solution 
and then further diluted to constant solids of 8% be-
fore detection. Pooled liquid plasma and concentrated 
plasma samples were also diluted to constant solids of 
8% before testing. The sample-to-positive (S/P) ratio 
was calculated by dividing the sample optical density 
at 450 nm by the positive control optical density, and 
samples with an S/P ratio of 0.2 or greater were con-
sidered positive.
PCV2 PCR. Deoxyribonucleic acid was extracted 
and immediately frozen at −20°C by using a QIAamp 
DNA Blood Mini Kit (Qiagen, Valencia, CA). The prim-
ers and probes designed for PCV2 open-reading frame 
1 were used for quantitative real-time PCR (Opriessnig 
et al., 2003). The real-time PCR reaction consisted of 
a 25-μL PCR mixture containing 12.5 μL of a commer-
cially available master mix (TaqMan Universal PCR 
master mix, Applied Biosystems, Carlsbad, CA), 2.5 
μL of DNA, 1 μL (0.4 μmol) of each primer, and 0.5 
μL (0.2 μmol) of probe. The reaction was run in a 7500 
Fast Real-Time PCR system (Applied Biosystems) un-
der the following conditions: 50°C for 2 min, 95°C for 
10 min, followed by 40 cycles of 95°C for 15 s and 60°C 
for 1 min. Serial dilutions of a recombinant PCV2 DNA 
clone were included in each plate to generate a stan-
dard curve. Viral concentrations were expressed as the 
viral DNA copy numbers per milliliter of sample.
For PCV2a/b open-reading frame 2 differential PCR, 
a forward (5′-GCAGGGCCAGAATTCAACC-3′) and a 
reverse primer (5′-GGCGGTGGACATGATGAGA-3′), 
a probe specific for PCV2a (5′-Cal Fluor Orange 
560-GGGGACCAACAAAATCTCTATACCCTTT-
BHQ-3′), and a probe specific for PCV2b (5′-Quasar 
670-CTCAAACCCCCGCTCTGTGCCC-BHQ-3′) 
were designed in the Cap-coding region of PCV2. The 
multiplex real-time PCR reaction consisted of a total 
volume of 25 μL containing 12.5 μL of the commer-
cially available master mix (Applied Biosystems), 5 μL 
of DNA, 0.4 μmol of each primer, and 0.2 μmol of each 
of the probes. The reactions were carried out under 
the following conditions: 50°C for 2 min, 95°C for 10 
min, followed by 40 cycles of 95°C for 15 s and 60°C 
for 1 min. The sensitivity and specificity of the real-
time PCR reaction were evaluated by using known PC-
V2a and PCV2b isolates as well as porcine parvovirus, 
porcine reproductive and respiratory syndrome virus 
(PRRSV), and PCV1 isolates.
Statistical Analysis. Experimental data were an-
alyzed for each region (Southeast or Midwest) by ANO-
VA, using PROC GLM (SAS Inst. Inc., Cary, NC). 
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Least squares means are reported for abattoir samples. 
A P-value of less than 0.05 was considered statistically 
significant throughout this study. Real-time PCR re-
sults (copies/mL of plasma) were log10 transformed be-
fore statistical analysis. Because of the different solids 
concentrations of abattoir samples, all samples were 
transformed to a DM basis before analysis and are re-
ported in the tables on a DM basis. A χ2 analysis was 
used to analyze differences in prevalence.
Bioassay
Animals and Housing. Colostrum-fed, crossbred, 
specific-pathogen-free, 10-wk-old pigs (approximately 
68 kg of BW) were purchased from a herd that is rou-
tinely tested for major swine pathogens and known 
to be free of PCV2, PRRSV, porcine parvovirus, and 
swine influenza virus. Pigs were housed individually in 
separate rooms. Each room had 18 m2 of solid concrete 
floor space, separate ventilation systems, and 1 nipple 
drinker.
Experimental Design and Treatments. In a 
completely randomized design, 9 pigs were randomly 
divided into 3 treatment groups, which included 1) a 
negative control (no plasma in the feed, not inoculated 
with PCV2); 2) a positive control (no plasma in the 
feed, inoculated with PCV2); and 3) plasma-fed pigs 
(4% porcine plasma in the feed for 42 d, not inoculated 
with PCV2). The diets in treatments 1 and 2 did not 
contain any animal protein except for dried whey. All 
diets were formulated to meet the nutritional require-
ments of the pig (NRC, 1998) and were provided on 
the floor to ensure ad libitum consumption. Pigs in 
treatment 2 were inoculated intranasally with 1.5 mL 
of PCV2b isolate NC-16845 at a tissue culture infec-
tive dose (TCID50) of 10
4.5/mL. Blood samples (ap-
proximately 5 mL) were collected in serum separator 
tubes (Fisher Scientific, Pittsburgh, PA) on arrival, on 
the day of inoculation, and weekly thereafter for 42 
d. Blood was centrifuged at 2,000 × g for 10 min at 
4°C and tested for the presence of anti-PCV2-IgG (de-
scribed in the PCV2 Serology section) antibodies and 
PCV2 DNA (described in the PCV2 PCR section).
Spray-Dried Plasma. The commercially pro-
duced spray-dried plasma used in this trial was selected 
from 2 lots containing increased PCV2 DNA loads (6.7 
and 6.4 log10 copies/g, respectively), and ELISA S/P 
ratios of 1.214 and 1.034 in a dilution of 0.25 g/mL. 
The 2 lots of plasma were blended 50:50 and then in-
corporated into the complete feed, for a final inclusion 
of 4%. Based on average intake of 2.57 kg/d for a 65-kg 
pig fed for 42 d, average plasma consumption would be 
103 g/d, for a total consumption of 4.33 kg of spray-
dried plasma per pig.
Necropsy. All pigs were humanely euthanized by 
pentobarbital overdose (Fatal-Plus, Vortech Pharma-
ceuticals Ltd., Dearborn, MI) and necropsied at 42 d 
postinoculation (dpi). The severity of macroscopic lung 
lesions (ranging from 0 to 100%) was estimated in a 
blinded fashion as described previously (Opriessnig et 
al., 2006). Sections of the lymph nodes (superficial in-
guinal, mediastinal, tracheobronchial, mesenteric), ton-
sils, thymus, ileum, kidneys, colon, spleen, and liver 
were collected at necropsy and fixed in 10% neutral-
buffered formalin and routinely processed for histologi-
cal examination.
Histopathology. Microscopic lesions were evalu-
ated by a veterinary pathologist blinded to treatment 
groups. Lung sections were scored for the presence 
and severity of interstitial pneumonia, ranging from 
0 (normal) to 6 (severe diffuse; Halbur et al., 1995). 
Sections of the heart, liver, kidneys, ileum, and colon 
were evaluated for the presence of lymphohistiocytic 
inflammation and scored from 0 (none) to 3 (severe). 
Lymphoid tissues, including the lymph nodes, tonsils, 
and spleen, were evaluated for the presence of lymphoid 
depletion, ranging from 0 (normal) to 3 (severe), and 
for histiocytic inflammation and the replacement of fol-
licles, ranging from 0 (normal) to 3 (severe; Opriessnig 
et al., 2004).
PCV2 Immunohistochemistry. Porcine circo-
virus type 2-specific antigen detection was done by 
immunohistochemistry on selected formalin-fixed and 
paraffin-embedded sections of lymph nodes (superficial 
inguinal, mediastinal, tracheobronchial, and mesenter-
ic), tonsils, spleen, and thymus by using a rabbit poly-
clonal antiserum (Sorden et al., 1999). The amount of 
PCV2 antigen was scored by a pathologist blinded to 
treatment groups. Scores ranged from 0 (no signal) to 
3 (more than 50% of lymphoid follicles contained cells 
with PCV2 antigen staining; Opriessnig et al., 2004).
Statistical Analysis. Analysis of variance was 
used to determine significant differences among groups. 
Real-time PCR results (copy numbers) were log10 trans-
formed before statistical analysis. If an ANOVA result 
was significant (P < 0.05), Student’s t-tests were used 
to determine which groups were different. Statistical 
analysis of the data was performed with JMP software 
(SAS Inst. Inc.).
RESULTS
Spray-Dried Plasma Survey
PCV2 Antibody Status in Different Sample 
Types and Regions. Fresh, concentrated liquid, and 
spray-dried plasma samples from within and across the 
Midwest or Southeast regions were compared (Tables 1 
and 2). All fresh (52/52), concentrated liquid (32/32), 
and spray-dried (32/32) plasma samples contained anti-
bodies to PCV2, with mean ELISA S/P ratios (±SEM) 
on a DM basis of 12.9 ± 0.4, 12.0 ± 0.7, and 10.3 ± 0.3, 
respectively. By region, ELISA S/P ratios (DM basis) 
in the Midwest were less (P < 0.05) in concentrated liq-
uid compared with fresh plasma samples, whereas the 
ratio in the spray-dried samples was intermediate. In 
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the Southeast, ELISA S/P ratios (DM basis) decreased 
(P < 0.05) from fresh to spray-dried samples. Overall, 
samples from the Southeast region had a greater an-
tibody content for PCV2 compared with those in the 
Midwest.
PCV2 DNA Status in Different Sample 
Types and Regions. In total, PCV2 DNA was pres-
ent in 82.7% (43/52) of the fresh plasma samples, with 
a mean log10 PCV2 DNA load of 6.5 ± 0.4 on a DM 
basis. Porcine circovirus type 2a and PCV2b were de-
tected in 25% (13/52) and 82.7% (43/52) of the sam-
ples, respectively. Porcine circovirus type 2 DNA was 
detected in 71.9% (23/32) of the concentrated liquid 
plasma samples, with a mean log10 PCV2 DNA load 
of 5.3 ± 0.6 on a DM basis. Porcine circovirus type 
2a was detected in 3.1% (1/32) of the concentrated 
plasma samples, whereas PCV2b was detected in 71.9% 
(23/32) of the samples. Twenty-five of the 32 (78.1%) 
spray-dried plasma samples were positive for PCV2 
DNA, with a mean log10 PCV2 DNA load of 5.9 ± 0.6 
on a DM basis. Porcine circovirus type 2a and PCV2b 
were detected in 28.1% (9/32) and 71.9% (23/32) of the 
spray-dried plasma samples, respectively.
Within region, the prevalence of PCV2 DNA in fresh 
plasma samples was not different (P > 0.05); how-
ever, the Midwest had a greater prevalence than the 
Southeast, with a 100.0% prevalence compared with a 
67.9% prevalence (Tables 1 and 2). Concentrated liquid 
plasma samples from the Midwest had a significantly 
(P < 0.03) smaller mean log10 PCV2 DNA load com-
pared with fresh or spray-dried plasma samples (Table 
1), which may be the result of a decreased incidence. 
No difference (P > 0.05) in the mean log10 PCV2 DNA 
load was noted in the Southeast among different sam-
ple types (Table 2).
Comparison of In-Process Liquid and Spray-
Dried Plasma Samples at Different Stages of 
Production. Concentrated liquid and spray-dried 
plasma samples collected from different production 
stages (beginning, middle 1, middle 2, and end) were 
compared for their PCV2 antibody and DNA status 
(Table 3). During the production run, there was no sig-
nificant change (P > 0.05) in the quantity or prevalence 
of anti-PCV2 antibodies or the load of PCV2 DNA.
Bioassay
Clinical Presentation, Gross and Micro-
scopic Lesions. Clinical disease was not observed 
in any of the treatment groups. No gross lung lesions 
were observed in the negative control pigs or the pigs 
fed spray-dried plasma. Two of 3 positive control pigs 
had mild gross lung lesions (mean score of 3.3 ± 2.4), 
characterized by multifocal red to purple consolidation.
Microscopically, none of the negative control pigs had 
lesions, 1 of the 3 pigs fed spray-dried plasma had mild 
lymphoid depletion in the tonsils and lymph nodes, and 
2 of the 3 positive control pigs had mild to severe lym-
Table 1. Porcine circovirus type 2 (PCV2) antibody and DNA copies of fresh, concen-
trated liquid, and spray-dried plasma samples from a Midwest slaughter region 
Sample type Fresh Concentrated liquid Spray dried SEM
No. of samples 24 12 12
PCV2 ELISA1
 S/P ratio2 12.44a 9.16b 11.44ab 0.92
 Prevalence, % 100 100 100 0
PCV2 DNA1
 Log10 copies/mL 7.92
a 6.45b 7.76a 0.35
 Prevalence, % 100 91.7 100 4.12
a,bWithin a row, means without a common superscript differ (P < 0.03).
1Porcine circovirus type 2 ELISA and DNA expressed on a DM basis.
2Sample-to-positive ratio.
Table 2. Porcine circovirus type 2 (PCV2) antibody and DNA copies of fresh, concen-
trated liquid, and spray-dried plasma samples from a Southeast slaughter region 
Sample type Fresh Concentrated liquid Spray dried SEM
No. of samples 28 20 20
PCV2 ELISA1     
 S/P ratio2 13.32b 13.66b 9.63a 0.58
 Prevalence, % 100 100 100 0
PCV2 DNA1
 Log10 copies/mL 5.22 4.56 4.76 0.83
 Prevalence, % 67.9 60 65 10.9
a,bWithin a row, means without a common superscript differ (P = 0.0001).
1Porcine circovirus type 2 ELISA and DNA expressed on a DM basis.
2Sample-to-positive ratio.
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phoid depletion and histiocytic replacement of follicles 
in the tonsils, spleen, and lymph nodes.
Anti-PCV2-IgG Antibody Levels. On arrival, 
all pigs were negative for the PCV2 antibody (Figure 
1). The negative control pigs and pigs fed spray-dried 
plasma remained negative for the anti-PCV2 antibody 
throughout the study. Two of 3 positive control pigs 
were seropositive for PCV2 at 28 and 35 dpi, and by 42 
dpi, all 3 pigs had seroconverted to PCV2.
PCV2 Viremia and Antigen in Tissues. All 
serum samples collected at the beginning of the trial 
were negative for PCV2 DNA. Negative control pigs 
and pigs fed spray-dried plasma remained negative for 
PCV2 DNA in the serum throughout the study (Fig-
ure 1). After inoculation, all positive control pigs be-
came PCV2 viremic by 7 dpi and remained PCV2 PCR 
positive until the termination of the study (Figure 1), 
indicating that these animals were highly susceptible 
to PCV2. Porcine circovirus type 2 antigen was not 
detected in any of the negative control pigs or pigs fed 
spray-dried plasma. One of 3 positive control pigs had 
low amounts of PCV2 antigen in the tonsils.
DISCUSSION
The prevalence of PCV2 in subclinically infected 
slaughter pigs is common (Segalés and Domingo, 2002; 
Opriessnig et al., 2007). Porcine circovirus type 2 is 
a stable virus resistant to heat treatment (Welch et 
al., 2006). Spray-dried porcine plasma collected from 
Table 3. Prevalence and amount of porcine circovirus type 2 (PCV2) antibody and DNA in concentrated and 
spray-dried plasma samples at different stages of production (mean ± SEM) 
Plasma type Stage1
PCV2 ELISA2 PCV2 DNA2
Prevalence,  
No./No. (%) S/P ratio3
Prevalence,  
No./No. (%)
Log10  
copies/mL
Concentrated liquid Beginning 8/8 (100) 12.8 ± 1.6 6/8 (75.0) 5.5 ± 1.2
Middle 1 8/8 (100) 12.6 ± 1.3 5/8 (62.5) 4.8 ± 1.4
Middle 2 8/8 (100) 13.1 ± 1.3 6/8 (75.0) 5.4 ± 1.2
End 8/8 (100) 9.4 ± 1.2 6/8 (75.0) 5.4 ± 1.2
Spray dried Beginning 8/8 (100) 10.3 ± 0.9 7/8 (87.5) 6.6 ± 1.0
Middle 1 8/8 (100) 10.5 ± 0.6 5/8 (62.5) 4.8 ± 1.4
Middle 2 8/8 (100) 10.6 ± 0.5 7/8 (87.5) 6.5 ± 1.0
End 8/8 (100) 9.8 ± 0.7 6/8 (75.0) 5.6 ± 1.2
1Samples were taken after initial stabilization of the spray-drying process at the start of each run (beginning), after approximately one-third of 
the production run (middle 1), after approximately two-thirds of the production run (middle 2), and just before the spray dryer shut down (end 
of the production run).
2Porcine circovirus type 2 ELISA and DNA expressed on a DM basis.
3Sample-to-positive ratio.
Figure 1. Porcine circovirus type 2 (PCV2) ELISA sample-to-positive ratios (bars) and amount of PCV2 DNA (lines) for treatment 1 pigs 
(negative control, no plasma in the feed, not inoculated with PCV2), treatment 2 pigs (positive control, no plasma in the feed, inoculated with 
PCV2), and treatment 3 pigs (4% porcine plasma in the feed for 42 d, not inoculated with PCV2). Error bars show the SEM in each group.
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slaughter pigs is commonly included as an ingredient 
in nursery feeds (USDA, 2008). There are conflicting 
reports in the literature evaluating the potential for 
spray-dried porcine plasma included in swine feeds to 
be a vector for spreading PCV2. Pujols et al. (2008) 
reported that naïve pigs did not develop PCV2 vire-
mia and had no evidence of seroconversion to PCV2 
when fed a diet containing an increased quantity (8% 
plasma) of commercially produced porcine plasma that 
was PCR positive for PCV2 DNA (5.4 log10 copies/mL) 
for 45 d. In contrast, Patterson et al. (2010) reported 
that it is possible to transmit PCV2 to naïve pigs fed 
experimentally produced spray-dried porcine plasma 
collected from a single PCV2-infected pig exhibiting 
clinical symptoms of PCVAD. Thus, the current studies 
were done to investigate the prevalence of PCV2 DNA 
and antibody in commercially produced porcine plasma 
and the infectivity of PCV2 DNA-positive commercial 
spray-dried plasma fed to PCV2-naïve pigs.
The source animals for commercially produced por-
cine plasma are significantly different from the source 
animal reported by Patterson et al. (2010). Commer-
cially available porcine plasma, including that used in 
the current study, is collected at federally inspected 
abattoirs from pigs that have passed antemortem in-
spection as fit for slaughter for human consumption, 
decreasing the chances for collection of plasma from a 
clinically affected animal. Typically, plasma is separat-
ed from the cellular fraction immediately after collec-
tion, chilled, and stored in insulated tanks. Daily, the 
liquid plasma is transported to the spray-drying facility 
in insulated tanker trucks containing plasma from ap-
proximately 9,000 to 10,000 pigs. At the spray-drying 
facility, the tanker load is stored in an insulated silo 
with 1 to 3 additional loads before further processing. 
Therefore, plasma from a single pig is pooled with that 
from 9,000 to 30,000 other pigs. Although a single pig 
may not have antibodies to all pathogens present in the 
population, pooling of such large numbers of animals 
results in a mixture likely to contain antibodies to all 
pathogens circulating in the population at any point in 
time (Borg et al., 2002). Pooling of plasma containing 
neutralizing antibodies with plasma containing patho-
gens such as viruses is recognized as a way to ensure 
neutralization of potentially contaminating viruses, es-
pecially stable viruses that are difficult to inactivate 
by other methods (Solheim et al., 2008; Williams and 
Khan, 2010).
During the time period when the commercially col-
lected plasma was sampled, the incidence of PCV2 
DNA was high (82.7%). The Midwest had a greater 
prevalence of PCV2 DNA in plasma samples collected 
from pigs slaughtered at the abattoirs compared with 
the Southeast. However, 100% of the samples contained 
anti-PCV2 antibodies. These data are consistent with 
serological surveys that have shown 100% of the inves-
tigated farms or individual pigs to be seropositive for 
PCV2 (Allan and Ellis, 2000; Walker et al., 2000; Zhou 
et al., 2006). Processing fresh plasma at commercial 
spray-drying facilities had little effect from beginning 
to end on the presence or quantity of detectable PCV2 
DNA or on detectable anti-PCV2 antibodies. Although 
the PCV2-neutralizing antibody was not measured in 
the spray-dried plasma samples, it has been reported 
that the quantity of PCV2-neutralizing antibodies coin-
cides with the amount of antibodies detected by ELISA 
in PCVAD-free pigs (Meerts et al., 2006). In contrast, 
PCVAD-affected animals may have PCV2 antibodies, 
but neutralizing antibodies are very low or undetect-
able (Meerts et al., 2005, 2006). Therefore, considering 
the reduced PCV2 DNA in fresh, concentrated liquid, 
and spray-dried plasma samples and the health status 
of the source pigs at slaughter, it could be speculated 
that the final spray-dried plasma products contained 
PCV2-neutralizing antibodies that correlated with an-
tibodies in the current study.
In the present animal trial, commercial spray-dried 
porcine plasma was selected from the available inven-
tory based on the greatest amount of PCV2 DNA de-
tected (6.7 log10 copies/g). The experimental design 
included a treatment in which the pigs were challenged 
directly with PCV2, demonstrating that the experi-
mental pigs were susceptible to PCV2 infection. In this 
experiment, pigs inoculated with PCV2 (positive con-
trols) became viremic by 7 dpi and remained viremic 
throughout the study. Additionally, all positive control 
pigs seroconverted to PCV2 by 42 dpi. However, at 
no time during the experiment did pigs consuming the 
diet containing spray-dried plasma become infected, as 
evidenced by the lack of PCV2 antigen in the tissues, 
lack of PCV2 viremia, or lack of PCV2 seroconversion. 
These data are consistent with those of Pujols et al. 
(2008). In contrast, Patterson et al. (2010) reported 
that spray-dried plasma collected from a single pig ex-
perimentally infected with PCV2 while exhibiting clini-
cal symptoms of PCVAD was capable of transmitting 
PCV2. It is likely that differences in the source animals 
from which the inocula were produced contributed to 
the differences in results reported in these studies (Pu-
jols et al., 2008; Patterson et al., 2010).
Spray drying is the transformation of a feed from 
a fluid state into a dried particulate by spraying the 
feed into a gaseous drying medium. The spray-drying 
process can be divided into 3 significant steps, includ-
ing atomization of the liquid feed, interaction of the 
liquid droplet with the drying gases, and separation of 
the dried powder from the drying gases (Cal and Sol-
lohub, 2010; Sollohub and Cal, 2010). The conditions 
in each step can affect the physical characteristics of 
the powder and microbial survival (Sollohub and Cal, 
2010). For example, atomization can affect the droplet 
size, which in turn affects the rate of water evapora-
tion from the particle and microbial survival (Praba-
karan and Hoti, 2008; Thybo et al., 2008a). The angu-
lar momentum of a rotary atomizer affects shear forces 
during atomization and subsequent microbial survival 
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(Luna-Solano et al., 2005). The temperature of the dry-
ing gas affects the rate of evaporation and subsequent 
outlet temperature. The outlet temperature and rapid 
changes in temperature and pressure exert significant 
effects on microbial survival (To and Etzel, 1997a,b; 
Lian et al., 2002; Ananta et al., 2005). The design of 
the drying chamber affects the air flow and retention 
time of the particle within the drying chamber (Foster 
and Leatherman, 1995). The total time exposed to in-
creased temperatures has been shown to affect micro-
bial survival (APC Inc., Ankeny, IA, unpublished data) 
and is affected by the design of the system separating 
the dried particle from the heated air and transport-
ing the dry powder to final packaging. Because the de-
sign and configuration of the spray-drying process have 
been shown to affect the effectiveness of spray drying, 
including microbial survival, it has been suggested that 
it may not be appropriate to fully extrapolate data 
from a laboratory spray drier to commercial spray dry-
ing (Thybo et al., 2008b). Spray drying has been shown 
to inactivate microbes (both bacterial and viral) in ani-
mal plasma. Pseudorabies virus (105.3 TCID50/mL) and 
PRRSV (103.5 to 104.0 TCID50/mL) were both inacti-
vated when added to bovine plasma and spray dried at 
an outlet temperature of 90°C, as evidenced by the ab-
sence of viable virus detected in 4 consecutive passages 
of cell cultures (Polo et al., 2005). Additionally, feeding 
6-wk-old pigs a diet containing 8% spray-dried plasma 
for 63 d failed to elicit antibodies against parvovirus (a 
known virus model for heat-resistant viruses), PRRSV, 
or pseudorabies virus while improving the growth of 
pigs (Polo et al., 2005). However, PCV2 is resistant 
to heat inactivation (Welch et al., 2006). Freeze-dried 
PCV2 was shown to be resistant to dry-heat treatment 
at 120°C for 30 min (Welch et al., 2006). Other data 
demonstrated that the PCV2 could be completely in-
activated after wet-heat treatment at 80°C for 15 min 
(O’Dea et al., 2008). It is likely that differences in the 
design and configuration of the spray-drying process 
between commercial production and a laboratory-scale 
drying system and the heat stability of PCV2 contrib-
uted to the contrasting results reported by Patterson 
et al. (2010) and Pujols et al. (2008), and the current 
study.
A greater serum PCV2 load has been correlated with 
an increased clinical severity of PCVAD in pigs (Brun-
borg et al., 2004; Krakowka et al., 2005; Segalés et al., 
2005; McIntosh et al., 2009). It has been reported that 
PCVAD-affected pigs have a 3.0-log greater PCV2 load 
than nonaffected pigs (McIntosh et al., 2009), and 7.0 
log10 has been suggested as the threshold for PCVAD 
diagnosis (Olvera et al., 2004). In the present study, al-
though an increased prevalence of PCV2 DNA (82.7%) 
was detected in fresh plasma samples collected direct-
ly from abattoirs, the relatively low amount of PCV2 
DNA (5.2 ± 0.7 log10; as-is basis) in the commercial 
spray-dried plasma suggested, as expected, that the 
source plasma was from subclinically infected pigs. The 
reduced PCV2 DNA load found in commercial plasma, 
compared with the experimental plasma used by Pat-
terson et al. (2010), may contribute to differences be-
tween studies in the literature and the current study.
Significant differences exist between the studies re-
ported by Pujols et al. (2008), Patterson et al. (2010), 
and the current study. These differences include the 
health status of the source animals, the pooling of plas-
ma from numerous animals, the design of the spray-
drying equipment, and the PCV2 DNA load in the 
plasma. It is likely that a combination of these factors 
contributed to the differences in the reported results. In 
summary, the occurrence of PCV2 DNA and anti-PCV2 
antibodies in spray-dried porcine plasma collected in 
the Midwest and East regions of the United States is 
widespread. However, the data from this study indicate 
that spray-dried porcine plasma as commercially col-
lected and processed does not represent a significant 
risk factor for the transmission of PCV2 infection in 
commercial swine production when included in the ra-
tion as a feed ingredient.
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